Taltz

Medicinal product

(Invented) name

Taltz

Active substance (s)

Iksekizumabas

Strength

40 mg

Pharmaceutical form

injekcinis tirpalas užpildytame švirkšte

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AC13, Ixekizumab

Marketing authorisation holder

Eli Lilly and Company (Ireland) Limited, Airija

Date of authorisation

2016-04-25

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Užpildytame švirkšte (0,5 ml tirpalo) yra	0.5 ml
Iksekizumabas	40 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117175	103275	1103275	užpildytas švirkštas	0,5 ml N1		Receptinis	EU/1/15/1085/007	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2016-04-25	Registruotas